Prizes
- 3 results
Search results
-
Targeting of DNMT3B in the plasma cell cancer multiple myeloma disturbs cancer cell growth and clonogenicity and boosts the anti-tumor activity of the proteasome inhibitor bortezomib
Muylaert, Catharina (Recipient), 30 Sep 2022
Prize: Prize (including medals and awards)
-
The de novo DNA methyltransferase DNMT3B: A new promising target in multiple myeloma
Muylaert, Catharina (Recipient), 2022
Prize: Prize (including medals and awards)
-
The de novo DNA methyltransferase DNMT3B plays an important role in multiple myeloma cell growth, clonogenicity and drug response
Muylaert, Catharina (Recipient), 19 Nov 2022
Prize: Prize (including medals and awards)